WisdomTree BioRevolution UCITS ETF AccumUSD (GB:WDNA) Price & Chart
GB:WDNA ETF Chart & Stats
- Day’s Range
- $26.76 - $27.70
- 52-Week Range
- $17.17 - $27.86
- Previous Close
- $26.85
- Volume
- 763
- Average Volume (3M)
- 3,154
- AUM
- 42.02M
- NAV
- 27.79
- Expense Ratio
- 0.46%
- Holdings Count
- 85
- Beta
- 0.98
- Inception Date
- Dec 03, 2021
- Last Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
- Shares Outstanding
- 1,461,000
- Standard Deviation
- N/A
ETF Overview
WisdomTree BioRevolution UCITS ETF AccumUSD
The WisdomTree BioRevolution UCITS ETF AccumUSD (Ticker: GB:WDNA) is a pioneering investment vehicle designed to capture the transformative potential within the genomic advancements niche. This sector-focused ETF provides exposure to a curated portfolio of companies at the forefront of the biotechnology revolution, targeting breakthroughs in genetic research, biotechnology innovations, and genomic medicine. By investing in this ETF, investors have the opportunity to align with a thematic strategy that taps into the burgeoning fields of gene editing, personalized medicine, and bioinformatics, all of which are poised to redefine the healthcare landscape. The WisdomTree BioRevolution UCITS ETF stands out by offering a unique blend of growth potential and diversification within the genomic sector, making it an ideal choice for those looking to capitalize on the next wave of biotechnological innovation.
WisdomTree BioRevolution UCITS ETF AccumUSD (GB:WDNA) Fund Flow Chart
GB:WDNA ETF FAQ
What was GB:WDNA’s price range in the past 12 months?
What is the AUM of GB:WDNA?
Is GB:WDNA overvalued?
How many shares outstanding does GB:WDNA have?
GB:WDNA ETF Smart Score
Top 10 Holdings
| Name | Weight % |
|---|---|
| TWSTTwist Bioscience | 3.83% |
| TEMTempus AI, Inc. Class A | 3.43% |
| LLYEli Lilly And Company | 3.33% |
| NTRANatera Inc. | 3.03% |
| IMNMImmunome, Inc. | 2.83% |
| MRNAModerna | 2.67% |
| TMOThermo Fisher Scientific | 2.46% |
| TXG10X Genomics | 2.43% |
| STOKStoke Therapeutics | 2.21% |
| UTHRUnited Therapeutics Corp. | 2.16% |
| Total | 28.38% |